← SynDRA
CANTHARIDIN
SynDRA canonical compound SYN0002331 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | protein phosphatase inhibitor |
|---|
| Indication | blisters |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
- protein phosphatase inhibitor
- PPP1CA INHIBITOR
Drug classes
- Enzyme Inhibitors
- Irritants
- Noxae
Cross-references
Synonyms
- ycanth
- Cantaridina
- Cantharides camphor
- Cantharidine
- Cantharidinum
- NSC-61805
- Ycanth
- DSSTox_CID_21752
- DSSTox_RID_79835
- DSSTox_GSID_41752
- CAS-56-25-7
- NCGC00016247-01
- Spectrum_001114
- SpecPlus_000537
- Spectrum4_000920
- Spectrum2_000630
- Prestwick0_000885
- Spectrum3_000621
- Prestwick1_000885
- Spectrum5_001618
- Prestwick2_000885
- KBioSS_001594
- KBioGR_001420
- BSPBio_002182
- MLS002153505
- SCHEMBL152261
- DivK1c_006633
- SPBio_002889
- SPBio_000600
- CHEMBL299846
- DTXSID7041752
- KBio2_006730
- KBio3_001682
- KBio2_004162
- KBio2_001594
- KBio1_001577
- MolPort-003-665-556
- HMS1570B12
Reported adverse events
- Application site erythema
- Application site pain
- Application site pruritus
- Application site vesicles
- Application site dryness
- Application site erosion
- Application site scab
Look up CANTHARIDIN in the interactive SynDRA portal →